The serum VAP-1 concentration differs between various CLDs, for example, patients with alcoholic liver diseases (ALDs) have higher VAP-1 concentrations when compared to those with primary biliary cholangitis and primary sclerosing cholangitis [6]. Here, AOC3 is linked to sclerosing cholangitis.